Mednet Logo
HomeNephrologyQuestion

How do you distinguish TMA caused by CNI toxicity versus antibody mediated rejection in a kidney transplant patient?

1
1 Answers
Mednet Member
Mednet Member
Nephrology · UCSF

It really boils down to "the company you keep". If the biopsy shows evidence of antibody-mediated rejection with peritubular capillaritis, glomerulitis, or C4d positivity, I would lean towards AMR-associated TMA. Also need to always consider whether the primary cause of the ESKD. Was there an undiag...

Register or Sign In to see full answer

How do you distinguish TMA caused by CNI toxicity versus antibody mediated rejection in a kidney transplant patient? | Mednet